Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068454868> ?p ?o ?g. }
- W2068454868 endingPage "789" @default.
- W2068454868 startingPage "781" @default.
- W2068454868 abstract "Rheumatologists have long been focused on developing novel immunotherapeutic agents to manage such prototypic autoimmune diseases as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The ultimate challenge in providing immunosuppressive treatment for patients with RA and SLE has derived from the dilemma that both protective and harmful immune responses result from adaptive immune responses, mediated by highly diverse, antigen-specific T and B cells endowed with powerful effector functions and the ability for long-lasting memory. As regulatory/suppressor T cells can suppress immunity against any antigen, including self-antigens, they emerge as an ideal therapeutic target. Several distinct subtypes of CD8(+) suppressor cells (Ts) have been described that could find application in treating RA or SLE. In a xenograft model of human synovium, CD8(+)CD28(-)CD56(+) T cells effectively suppressed rheumatoid inflammation. Underlying mechanisms involve conditioning of antigen presenting cells (APC). Adoptively transferred CD8(+) T cells characterized by IL-16 secretion have also exhibited disease-inhibitory effects. In mice with polyarthritis, CD8(+) Ts suppressed inflammation by IFNgamma-mediated modulation of the tryptophan metabolism in APC. In SLE animal models, CD8(+) Ts induced by a synthetic peptide exerted suppressive activity mainly via the TGFbeta-Foxp3-PD1 pathway. CD8(+) Ts induced by histone peptides were found to downregulate disease activity by secreting TGFbeta. In essence, disease-specific approaches may be necessary to identify CD8(+) Ts optimally suited to treat immune dysfunctions in different autoimmune syndromes." @default.
- W2068454868 created "2016-06-24" @default.
- W2068454868 creator A5006681271 @default.
- W2068454868 creator A5056587089 @default.
- W2068454868 creator A5085010400 @default.
- W2068454868 creator A5089281465 @default.
- W2068454868 date "2008-11-01" @default.
- W2068454868 modified "2023-10-09" @default.
- W2068454868 title "Inhibitory CD8+ T cells in autoimmune disease" @default.
- W2068454868 cites W103980742 @default.
- W2068454868 cites W1484000129 @default.
- W2068454868 cites W1485021502 @default.
- W2068454868 cites W1506106830 @default.
- W2068454868 cites W1507222414 @default.
- W2068454868 cites W1549813762 @default.
- W2068454868 cites W1552885427 @default.
- W2068454868 cites W1553630025 @default.
- W2068454868 cites W1567420244 @default.
- W2068454868 cites W1568356880 @default.
- W2068454868 cites W1575489109 @default.
- W2068454868 cites W1577972394 @default.
- W2068454868 cites W1580488216 @default.
- W2068454868 cites W1601327424 @default.
- W2068454868 cites W1627814885 @default.
- W2068454868 cites W1636612575 @default.
- W2068454868 cites W1647776454 @default.
- W2068454868 cites W173166459 @default.
- W2068454868 cites W1780101594 @default.
- W2068454868 cites W1912532821 @default.
- W2068454868 cites W1956346551 @default.
- W2068454868 cites W1969418564 @default.
- W2068454868 cites W1969465117 @default.
- W2068454868 cites W1974437579 @default.
- W2068454868 cites W1975456210 @default.
- W2068454868 cites W1976008320 @default.
- W2068454868 cites W1976570199 @default.
- W2068454868 cites W1980690619 @default.
- W2068454868 cites W1991882299 @default.
- W2068454868 cites W1996378082 @default.
- W2068454868 cites W2002593275 @default.
- W2068454868 cites W2004751481 @default.
- W2068454868 cites W2009074857 @default.
- W2068454868 cites W2011180970 @default.
- W2068454868 cites W2012107785 @default.
- W2068454868 cites W2018008269 @default.
- W2068454868 cites W2021888273 @default.
- W2068454868 cites W2022022565 @default.
- W2068454868 cites W2023571876 @default.
- W2068454868 cites W2025813544 @default.
- W2068454868 cites W2026383080 @default.
- W2068454868 cites W2033330275 @default.
- W2068454868 cites W2035862262 @default.
- W2068454868 cites W2039683692 @default.
- W2068454868 cites W2043035909 @default.
- W2068454868 cites W2043476265 @default.
- W2068454868 cites W2044157028 @default.
- W2068454868 cites W2045736384 @default.
- W2068454868 cites W2046459432 @default.
- W2068454868 cites W2049850873 @default.
- W2068454868 cites W2068511629 @default.
- W2068454868 cites W2068875112 @default.
- W2068454868 cites W2069590385 @default.
- W2068454868 cites W2073166085 @default.
- W2068454868 cites W2079721061 @default.
- W2068454868 cites W2081379792 @default.
- W2068454868 cites W2081522241 @default.
- W2068454868 cites W2088067960 @default.
- W2068454868 cites W2089251437 @default.
- W2068454868 cites W2091517206 @default.
- W2068454868 cites W2093070034 @default.
- W2068454868 cites W2094900843 @default.
- W2068454868 cites W2101854922 @default.
- W2068454868 cites W2108782816 @default.
- W2068454868 cites W2108860192 @default.
- W2068454868 cites W2114187877 @default.
- W2068454868 cites W2115728037 @default.
- W2068454868 cites W2118174062 @default.
- W2068454868 cites W2123518168 @default.
- W2068454868 cites W2125171141 @default.
- W2068454868 cites W2128942120 @default.
- W2068454868 cites W2134868528 @default.
- W2068454868 cites W2136798761 @default.
- W2068454868 cites W2137569966 @default.
- W2068454868 cites W2156694159 @default.
- W2068454868 cites W2157040330 @default.
- W2068454868 cites W2158820172 @default.
- W2068454868 cites W2162351951 @default.
- W2068454868 cites W2168023764 @default.
- W2068454868 cites W2168972481 @default.
- W2068454868 cites W2170758122 @default.
- W2068454868 cites W2326966025 @default.
- W2068454868 cites W2461513816 @default.
- W2068454868 cites W4230676991 @default.
- W2068454868 cites W4313324526 @default.
- W2068454868 cites W4313342393 @default.
- W2068454868 doi "https://doi.org/10.1016/j.humimm.2008.08.283" @default.
- W2068454868 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2614126" @default.
- W2068454868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18812196" @default.